B/F/TAF shows lower ART switching rates and higher persistence among HIV patients, especially those with mental health or ...

Phung explained that prior response often guides selection: Patients who respond poorly to frontline therapy may move to CAR ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...

Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity ...

Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...

Marc S. Raab, MD, PhD, discusses the different ways that combination therapy that includes teclistamab can benefit patients ...

Panelists discussed these questions during a recent Institute for Value-Based Medicine® event held in Nashville, Tennessee, ...

1. Garg S, Donnenfeld E, Sheppard J, Epitropoulos A, Brady TC. Reproxalap improves ocular redness, tear production, and ...

Panelists explain that in the absence of head-to-head trial data, real-world evidence (RWE) becomes crucial in guiding ...

Panelists discuss how real-world outcomes inform patient conversations and support shared decision-making for third-line ...